Encompass Health CorporationEHCNYSE
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 86% recommend buying.

Consensus Rating
Buy
21 analysts·High coverage
86%
Rating Distribution
Strong Buy
15%
Buy
1781%
Hold
210%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Oct 30, 2025Barclays
Encompass Health price target raised to $150 from $141 at Barclays
Target:$150.00
+19.4%from $125.63
Oct 2, 2025UBS
Encompass Health price target raised to $150 from $140 at UBS
Target:$150.00
+20.5%from $124.52
Aug 14, 2025Truist Financial
Encompass Health price target raised to $140 from $135 at Truist
Target:$140.00
+17.4%from $119.30
Apr 28, 2025RBC Capital
Encompass Health price target raised to $125 from $110 at RBC Capital
Target:$125.00
+8.4%from $115.32
Sep 26, 2024RBC Capital
Encompass Health price target raised to $105 from $95 at RBC Capital
Target:$105.00
+8.5%from $96.75
Sep 25, 2024UBS
Encompass Health price target raised to $110 from $100 at UBS
Target:$110.00
+15.5%from $95.26
May 22, 2024RBC Capital
Encompass Health Corp (EHC) PT Raised to $95 at RBC Capital
Target:$95.00
+10.6%from $85.86
Apr 25, 2024Mizuho Securities
Encompass Health Corp (EHC) PT Raised to $95 at Mizuho
Target:$95.00
+14.7%from $82.80
Mar 28, 2024Barclays
Encompass Health Corp (EHC) PT Raised to $101 at Barclays
Target:$101.00
+23.5%from $81.79
May 3, 2022RBC Capital
RBC Capital Maintains Outperform on Encompass Health, Lowers Price Target to $85
Target:$85.00
+24.6%from $68.24
May 2, 2022Raymond James
Raymond James Maintains Strong Buy on Encompass Health, Raises Price Target to $85
Target:$85.00
+23.5%from $68.83
Apr 29, 2022Credit Suisse
Credit Suisse Maintains Outperform on Encompass Health, Raises Price Target to $83
Target:$83.00
+21.2%from $68.46
Apr 29, 2021Stephens
Encompass Health Corp (EHC) PT Raised to $100 at Stephens
Target:$100.00
+18.2%from $84.62